| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.003 | 1 |